Clinical Trial Update: A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B) [Phase 3]

View source ↗

Summary

Phase III randomized trial AML-8B evaluating intensive consolidation with high-dose cytarabine in acute myeloid leukemia has completed. The update is posted on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Leukemia | Phase 3 | Status: COMPLETED